Emerald Health Therapeutics, Inc. Disclosure

 

Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) is a client of PCG Advisory, Inc. EMHTF has an agreement in place to pay PCG a monthly cash fee of $6,500, plus a one-time stock fee of 100,000 common stock options, restricted under Rule 144, for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.